314 related articles for article (PubMed ID: 17973302)
1. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
[No Abstract] [Full Text] [Related]
2. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
Osuna Molina R; Ferrer Ríos T; Gallego Gallegos R; Ramos Lora M; Ynfante Ferrús M; Figueruela López B
Rev Esp Enferm Dig; 2006 Jan; 98(1):60-1. PubMed ID: 16555939
[No Abstract] [Full Text] [Related]
3. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
Joosten AA; van Olffen GH; Hageman G
Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1470-2. PubMed ID: 12908351
[TBL] [Abstract][Full Text] [Related]
4. Pericarditis as a complication of infliximab therapy in Crohn's disease.
Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
[No Abstract] [Full Text] [Related]
5. [Listeria meningitis in a patient with Crohn's disease--a seldom, but clinically relevant adverse event of therapy with infliximab].
Dederichs F; Pinciu F; Gerhard H; Eveld K; Stallmach A
Z Gastroenterol; 2006 Aug; 44(8):657-60. PubMed ID: 16902896
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
[No Abstract] [Full Text] [Related]
7. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
Wagner TE; Huseby ES; Huseby JS
Am J Med; 2002 Jan; 112(1):67-9. PubMed ID: 11812409
[No Abstract] [Full Text] [Related]
8. Systemic amyloidosis with Crohn's disease treated with infliximab.
Park YK; Han DS; Eun CS
Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
[No Abstract] [Full Text] [Related]
9. Infliximab as first-line therapy for severe Crohn's disease?
Cohen RD
Inflamm Bowel Dis; 2002 Jan; 8(1):58-9; discussion 63-5. PubMed ID: 11837940
[No Abstract] [Full Text] [Related]
10. Infliximab treatment for Crohn's disease.
Conroy CA; Cattell R
Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
[No Abstract] [Full Text] [Related]
11. Infliximab as first-line therapy for Crohn's disease is premature.
Greenberg GR
Inflamm Bowel Dis; 2002 Jan; 8(1):60-2; discussion 63-5. PubMed ID: 11837941
[No Abstract] [Full Text] [Related]
12. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.
Ritz MA; Jost R
Inflamm Bowel Dis; 2001 Nov; 7(4):327. PubMed ID: 11720324
[No Abstract] [Full Text] [Related]
13. [Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis].
Ramanampamonjy RM; Laharie D; Bonnefoy B; Vergniol J; Amouretti M
Gastroenterol Clin Biol; 2006 Jan; 30(1):157-8. PubMed ID: 16514404
[No Abstract] [Full Text] [Related]
14. Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?
van Deventer SJ
Gut; 2002 Sep; 51(3):362-3. PubMed ID: 12171957
[No Abstract] [Full Text] [Related]
15. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
Rosales-Zábal JM; Fernández-Pérez F; Albandea-Moreno C; Vera-Rivero FM; Navarro-Jarabo JM
Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
[No Abstract] [Full Text] [Related]
16. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist.
Angelucci E; Cocco A; Viscido A; Vernia P; Caprilli R
Inflamm Bowel Dis; 2007 Aug; 13(8):1059-61. PubMed ID: 17387676
[No Abstract] [Full Text] [Related]
17. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
Mocciaro F; Russo G; Di Mitri R; Marino A
Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
[No Abstract] [Full Text] [Related]
18. Peripheral neuropathy with infliximab therapy in inflammatory bowel disease.
Burger DC; Florin TH
Inflamm Bowel Dis; 2009 Dec; 15(12):1772. PubMed ID: 19170193
[No Abstract] [Full Text] [Related]
19. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
Holtmann M; Wanitschke R; Helisch A; Bartenstein P; Galle PR; Neurath M
Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
Martínez F; Nos P; Benlloch S; Ponce J
Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
